Stage IVB Colon Cancer Terminated Phase 3 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0028588 (Stage IVB Colon Cancer)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00499369Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line TherapyTreatment